Weekly Newsletter Signup | Vendors, CIO Viewpoint, CXO Insights

Pharma Tech Outlook: Pharma Tech Magazine

Weekly Brief


Weekly Brief

May 12, 2022

Feature of the Week

The majority of experts agree that many people should be vaccinated against Covid-19, but they disagree on the ways to achieve it.  Read more
Pharmaceutical and life science industries are increasingly focusing on cutting-edge solutions based on enhanced pharma data analysis.  Read more
Biotechnology has always been centered on technology. However, emerging advanced computing technology,  Read more

CIO Viewpoint

By William Jason Cole, CIO, Meritus Health  
As we look to broaden the toolbox used to improve overall health for the population we serve, wearables undoubtably have a firm place in healthcare  Read more
By Matt Lasmanis, CIO, Information Technology, GSK  
Over the last decade, we’ve seen digital technology disrupt business as usual, drive remarkable returns for some companies, and utterly change the way we all live—from how we order a taxi to planning our next meal. But we are living in dynamic  Read more

Featured Vendors

By Douglas Zhang, Founder & CEO  
AbHelix leverages its proprietaryimmune sequencing technology platform with the vision to offer the required technologies to support immunotherapy research and development.  Read more
By Dragan Cicic, President and CEO  
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing ARC’s or Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Actinium’s lead...  Read more
By David Main, CEO and President  
Notch Therapeutics provides a technology platform that unlocks the ability to generate T cells and other immune cells from renewable stem cell lines, simplifying manufacturing and offering the ability to produce immune cells at scale. The...  Read more

CXO Insights

By Dr. Kim M. Bonner, BSc (Hons) VMD PhD, Executive Director, Clinical Development at Syneos Health  
Recent advances in immunotherapy, such as the use of checkpoint inhibitors, are transforming the...  Read more
By Ming Li, Director, Bioanalytical and Biomarker Outsourcing Operations, Alexion, AstraZeneca Rare Disease  
Bioanalysis is critical to pharmaceutical R&D in terms of providing pharmacokinetic, pharmacodynamic,...  Read more